Millipore Sigma Vibrant Logo

324832 EGFR Inhibitor II, BIBX1382 - CAS 196612-93-8 - Calbiochem

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
196612-93-8C₁₈H₁₉ClFN₇ • 2HCl • 2H₂O

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
324832-5MG
Comprobando disponibilidad...
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Ampolla de plást. 5 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      Solicitar precio
      Description
      OverviewA cell-permeable pyrimidopyrimidine compound that acts as a potent, reversible, ATP-competitive, and highly selective inhibitor of EGFR (ErbB-1, HER-1) both in cell-free enzymatic reactions (IC50 = 3 nM) and in culture (IC50 = 0.15, 1.82, and 3.2 µM in EGF-, HGF-, and FCS-dependent thymidine incorporation, respectively, in KB cells). It exhibits 1,000-fold greater selectivity over ErbB-2 (HER-2, neu; IC50 = 3.4 µM) and shows little activity towards IGF1R, β-InsRK, HGFR, c-src, and VEGFR-2 even at concentrations as high as 10 µM. Its antitumor efficacy has also been demonstrated in a murine xenograft model in vivo (10 mg/kg, daily, p.o.).
      Catalogue Number324832
      Brand Family Calbiochem®
      SynonymsN⁸-(3-Chloro-4-fluorophenyl)-N²-(1-methylpiperidin-4-yl)-pyrimido[5,4-d]pyrimidine-2,8-diamine, 2HCl, BIBX1382BS
      References
      ReferencesSolca, F.F., et al. 2004. J. Pharm. Exp. Ther. 311, 502.
      Egeblad, M., et al. 2001. Biochem. Biophys. Res. Commun. 281, 25.
      Nuijen, B., et al. 2000. Int. J. Pharm. 194, 261.
      Product Information
      CAS number196612-93-8
      ATP CompetitiveY
      FormYellow solid
      Hill FormulaC₁₈H₁₉ClFN₇ • 2HCl • 2H₂O
      Chemical formulaC₁₈H₁₉ClFN₇ • 2HCl • 2H₂O
      Hygroscopic Hygroscopic
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Application CommentsTocris suggests 50 mM solution can be made in water or DMSO. Aliquot & store at -20*C; stable for 6 months.
      Biological Information
      Primary TargetEGFR (ErbB-1, HER-1)
      Primary Target IC<sub>50</sub>3 nM against EGFR (ErbB-1, HER-1) in cell-free enzymatic reactions; 0.15, 1.82, and 3.2 µM in EGF-, HGF-, and FCS-dependent thymidine incorporation, respectively, in KB cells
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      324832-5MG 04055977215717

      Documentation

      Licencias necesarias

      Título
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      EGFR Inhibitor II, BIBX1382 - CAS 196612-93-8 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      EGFR Inhibitor II, BIBX1382 - CAS 196612-93-8 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      324832

      Referencias bibliográficas

      Visión general referencias
      Solca, F.F., et al. 2004. J. Pharm. Exp. Ther. 311, 502.
      Egeblad, M., et al. 2001. Biochem. Biophys. Res. Commun. 281, 25.
      Nuijen, B., et al. 2000. Int. J. Pharm. 194, 261.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision21-April-2011 JSW
      SynonymsN⁸-(3-Chloro-4-fluorophenyl)-N²-(1-methylpiperidin-4-yl)-pyrimido[5,4-d]pyrimidine-2,8-diamine, 2HCl, BIBX1382BS
      DescriptionA cell-permeable pyrimidopyrimidine compound that acts as a potent, reversible, ATP-competitive, and highly selective inhibitor of EGFR (ErbB-1, HER-1) both in cell-free enzymatic reactions (IC50 = 3 nM) and in culture (IC50 = 0.15, 1.82, and 3.2 µM in EGF-, HGF-, and FCS-dependent thymidine incorporation, respectively, in KB cells). It exhibits 1,000-fold greater selectivity over ErbB-2 (HER-2, neu; IC50 = 3.4 µM) and shows little activity towards IGF1R, β-InsRK, HGFR, c-src, and VEGFR-2 even at concentrations as high as 10 µM. Its antitumor efficacy has also been demonstrated in a murine xenograft model in vivo (daily p.o. dose 10 mg/kg).
      FormYellow solid
      CAS number196612-93-8
      Chemical formulaC₁₈H₁₉ClFN₇ • 2HCl • 2H₂O
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (25 mg/ml) or H₂O (1 mg/ml)
      CommentsTocris suggests 50 mM solution can be made in water or DMSO. Aliquot & store at -20*C; stable for 6 months.
      Storage Protect from light
      +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Irritant
      ReferencesSolca, F.F., et al. 2004. J. Pharm. Exp. Ther. 311, 502.
      Egeblad, M., et al. 2001. Biochem. Biophys. Res. Commun. 281, 25.
      Nuijen, B., et al. 2000. Int. J. Pharm. 194, 261.